Australian Clinical Labs Ltd (AU:ACL) has released an update.
Mitsubishi UFJ Financial Group, Inc. has ceased to be a substantial holder in Australian Clinical Labs Limited, as detailed in a recent Form 605, which documents a series of transactions involving the purchase and sale of securities by entities controlled by Morgan Stanley. The changes involved both acquisitions and disposals of ordinary shares, with significant numbers noted on 22 July 2024.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
